BMO Capital Downgrades Incyte to Underperform, Lowers Price Target to $48
Portfolio Pulse from Benzinga Newsdesk
BMO Capital has downgraded Incyte (NASDAQ:INCY) from Market Perform to Underperform and lowered its price target from $52 to $48.
July 02, 2024 | 9:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BMO Capital has downgraded Incyte from Market Perform to Underperform and reduced the price target from $52 to $48, indicating a negative outlook.
The downgrade from Market Perform to Underperform by BMO Capital suggests a negative outlook for Incyte. Additionally, the lowered price target from $52 to $48 indicates reduced expectations for the stock's performance. This is likely to result in a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100